Bosentan Therapy in Children With Functional Single Ventricle

Status Completed

Clinical Trial Summary

Bosentan is a kind of dual endothelin receptor antagonist.The purpose of this study is to investigate if Bosentan therapy can modify the outcome of children with functional single ventricle.

Clinical Trial Description

Increased pulmonary vascular resistance (PVR) is a serous issues in children with functional single ventricle during the staged operative period. The purpose of this study is to investigate if Bosentan therapy can improve the survival and life quality after staged Fontan procedure in the children with high risk of increased PVR. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01662037
Study type	Interventional
Source	Shanghai Jiao Tong University School of Medicine
Contact
Status	Completed
Phase	Phase 2
Start date	January 2010
Completion date	June 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01671566` - Interval Training in Adults With Congenital Heart Disease a Randomized Trial	N/A
Recruiting	`NCT01421030` - Outcomes in Patients and Their Closest Relatives Treated for Congenital Heart Disease With Catheter Based or Surgical Techniques	Phase 0
Withdrawn	`NCT00981591` - Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients	Phase 1/Phase 2
Completed	`NCT01567579` - An Evaluation of Routine Developmental Follow-Up in Infants and Children With Congenital Heart Disease
Terminated	`NCT00208676` - Using Tissue Doppler/Synchronization to Determine Heart Function in Children With Congenital Heart Disease	N/A
Completed	`NCT01941576` - Effects of rhBNP in Pediatrics After Corrective Repair of Tetralogy Of Fallot	N/A
Completed	`NCT01475357` - Intestinal Function in Neonates With Complex Congenital Heart Disease	N/A
Active, not recruiting	`NCT01227096` - Randomized Controlled Trial of the Effects of Electroacupuncture Preconditioning in Children Undergoing Cardiac Surgery	N/A
Completed	`NCT01201486` - Use of Color Doppler in Routine Examination of Fetal Heart in Second Trimester	N/A
Completed	`NCT00397514` - Assessing the Hemodynamic Benefits of Cardiac Resynchronization Therapy in Children Following Open-Heart Surgery	N/A
Completed	`NCT02232399` - Is Levosimendan Superior to Milrinone Regarding Acute Kidney Injury After Cardiac Surgery for Congenital Heart Disease?	Phase 2
Completed	`NCT05191654` - Investigation of Cardiopulmonary Parameters, Motor Development and Muscle Strength in DS With and Without CHD
Recruiting	`NCT06267859` - Development of Methods for Effective Treatment and Improvement of Common Somatic Diseases in Children	Early Phase 1
Completed	`NCT02320669` - Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass	Phase 3
Completed	`NCT01489475` - Plasma Angiopoietin Levels in Children Following Cardiopulmonary Bypass	N/A
Withdrawn	`NCT00579358` - Molecular Basis of Congenital Heart Defects
Recruiting	`NCT01196182` - Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)
Recruiting	`NCT03822442` - MRI to Predict Rejection and Failure in Transplant and Cardiomyopathy Patients
Recruiting	`NCT04382573` - Better Delineation of CDK13 Related Phenotype and Epigenetic Signature.
Completed	`NCT00450684` - Cardiac Resynchronization Therapy in Congenital Heart Defects	Phase 2/Phase 3